Venator Capital Management Ltd. Orgenesis Inc. Transaction History

Venator Capital Management Ltd.

  • $44.6 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$2.6 - $4.66 $398,442 - $714,131
-153,247 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$4.18 - $4.85 $634,327 - $736,002
-151,753 Reduced 49.76%
153,247 $685,000
Q2 2019

Aug 14, 2019
BUY
$3.86 - $5.2 $459,814 - $619,439
119,123 Added 64.09%
305,000 $1.36 Million
Q1 2019

May 15, 2019
BUY
$4.28 - $5.6 $795,553 - $1.04 Million
185,877 New
185,877 $991,000

Others Institutions Holding ORGS

# of Institutions
2
Shares Held
134K
Call Options Held
0
Put Options Held
0
View Full List

About Orgenesis Inc.

ORGS Quotes by TradingView
  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $75.4M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track Venator Capital Management Ltd. Portfolio

Follow Venator Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venator Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Venator Capital Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email